The AJMC® Psoriasis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin disease, which tends to go through cycles where it flares and goes into remission.
Smoking, Age, BMI, Previous Exposure Impact Response to Biologics for Psoriasis
Ixekizumab Improves Children’s Dermatology Life Quality Index Over 2 Years
Older Age Linked to Shorter Interval Between Psoriasis, Psoriatic Arthritis
Autoimmune Diseases Prevalent Among Patients With Psoriasis, Study Finds
A panel of experts discuss their personalized approaches to treating patients with psoriasis and comorbidities such as metabolic syndrome.
Dr Chesahna Kindred: Diverse Clinical Trials Are a Long-Game to Close the Health Equity Gaps
Dr Chesahna Kindred Addresses Diversity Barriers in Clinical Trials
Dr Chesahna Kindred Discusses the Strengths of Diversity in Psoriasis Clinical Trials
Dr Joseph Zabinski Discusses Challenges in Identifying Patients With GPP
Dr Joseph Zabinski Discusses Using Artificial Intelligence to Identify Patients With GPP
JNJ-2113 Shows Promising Response Rates Compared With Competitor Oral Therapies for Psoriasis
The Importance of Cultural, Social, and Clinical Diversity in Treating Plaque Psoriasis
Dr Mona Shahriari Talks Unique Challenges in Treating Psoriasis in Patients With Skin of Color
Dr Mona Shahriari Discusses Treatment of Plaque Psoriasis in Patients With Skin of Color
Final Thoughts on Psoriasis Across Skin Types
AJMC® Powered by Patients and Managed Care Insights – More Than a Cosmetic Disease: Vitiligo Treatment Approaches and Raising Awareness of the Disease Burden
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care